FI59999C - Foerfarande foer framstaellning av farmakologiskt vaerdefulla cyklopropylmetylamino- 2-oxazoliner - Google Patents

Foerfarande foer framstaellning av farmakologiskt vaerdefulla cyklopropylmetylamino- 2-oxazoliner Download PDF

Info

Publication number
FI59999C
FI59999C FI3985/73A FI398573A FI59999C FI 59999 C FI59999 C FI 59999C FI 3985/73 A FI3985/73 A FI 3985/73A FI 398573 A FI398573 A FI 398573A FI 59999 C FI59999 C FI 59999C
Authority
FI
Finland
Prior art keywords
formula
radical
hal
radicals
preparation
Prior art date
Application number
FI3985/73A
Other languages
English (en)
Finnish (fi)
Other versions
FI59999B (fi
Inventor
Charles Malen
Monique Desnos
Michel Laubie
Jean-Claude Poignant
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Priority to FI792226A priority Critical patent/FI792226A/fi
Priority to FI792225A priority patent/FI59095C/fi
Publication of FI59999B publication Critical patent/FI59999B/fi
Application granted granted Critical
Publication of FI59999C publication Critical patent/FI59999C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
    • C07C335/08—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/18—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI3985/73A 1972-12-28 1973-12-27 Foerfarande foer framstaellning av farmakologiskt vaerdefulla cyklopropylmetylamino- 2-oxazoliner FI59999C (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI792226A FI792226A (fi) 1972-12-28 1979-07-16 Foerfarande foer framstaellning av farmakologiskt vaerdefullt 2-(dicyklopropylmetylamino)imidazolin och salter haerav
FI792225A FI59095C (fi) 1972-12-28 1979-07-16 Foerfarande foer framstaellning av farmakologiskt vaerdefullt 2-(dicyklopropylmetylamino)-tiazolin och salter haerav

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5988672 1972-12-28
GB5988672A GB1453703A (en) 1972-12-28 1972-12-28 Substituted cyclopropylmethylamines processes for their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
FI59999B FI59999B (fi) 1981-07-31
FI59999C true FI59999C (fi) 1981-11-10

Family

ID=10484588

Family Applications (1)

Application Number Title Priority Date Filing Date
FI3985/73A FI59999C (fi) 1972-12-28 1973-12-27 Foerfarande foer framstaellning av farmakologiskt vaerdefulla cyklopropylmetylamino- 2-oxazoliner

Country Status (20)

Country Link
US (1) US3988464A (de)
JP (3) JPS5335949B2 (de)
AR (2) AR207336A1 (de)
AT (1) AT333272B (de)
BE (1) BE809179A (de)
CH (2) CH592641A5 (de)
CS (1) CS186258B2 (de)
DD (1) DD110869A5 (de)
DE (1) DE2362754C2 (de)
DK (1) DK145574C (de)
ES (1) ES421879A1 (de)
FI (1) FI59999C (de)
FR (1) FR2212143B1 (de)
GB (1) GB1453703A (de)
HU (1) HU169273B (de)
IL (3) IL43749A (de)
NL (1) NL169472C (de)
SE (1) SE388420B (de)
SU (2) SU505348A3 (de)
ZA (1) ZA739694B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2358890A1 (fr) * 1976-05-24 1978-02-17 Science Union & Cie Nouvelles aryl trifluoroethylamines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2432513A1 (fr) * 1977-10-24 1980-02-29 Merieux Inst Nouveaux derives de la thiazoline et leur application comme medicaments
DE2831600A1 (de) * 1978-07-19 1980-01-31 Boehringer Sohn Ingelheim Neue substituierte 2-phenylamino-1, 3-tetrahydropyrimidine-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
FR2444673A1 (fr) * 1978-12-20 1980-07-18 Science Union & Cie Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament
FR2669927B1 (fr) * 1990-11-29 1994-04-08 Adir Cie Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE19716237A1 (de) * 1997-04-18 1998-10-22 Basf Ag Substituierte Benzyloxyimino-Verbindungen
AUPP020297A0 (en) * 1997-11-05 1997-11-27 University Of Melbourne, The A novel receptor, and compounds which bind thereto
AU2003257418A1 (en) 2002-06-19 2004-01-06 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
US20060283363A1 (en) * 2005-06-07 2006-12-21 Wollman Albert E Potato Planter Improvement to Reduce Skips and Rolling
RU2534617C2 (ru) * 2012-09-21 2014-11-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Оренбургский государственный университет" Регулятор коллективного поведения ("чувство кворума") у бактерий
NZ717739A (en) 2013-08-09 2023-12-22 Ardelyx Inc Compounds and methods for inhibiting phosphate transport

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626067A (en) * 1965-07-01 1971-12-07 Du Pont Substituted oxazolines, useful as pharmaceuticals
NL128801C (de) * 1965-11-19
DE1670752A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-oxazolinen
DE1670753A1 (de) * 1966-09-27 1970-07-16 Bayer Ag Verfahren zur Herstellung von 2-Cycloalkylaminooxazolinen
DE1670751A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen

Also Published As

Publication number Publication date
IL49288A0 (en) 1976-05-31
DK145574C (da) 1983-05-30
FI59999B (fi) 1981-07-31
DE2362754C2 (de) 1985-11-21
FR2212143A1 (de) 1974-07-26
FR2212143B1 (de) 1977-03-11
NL169472C (nl) 1982-07-16
AU6340073A (en) 1975-06-12
AR211914A1 (es) 1978-04-14
ES421879A1 (es) 1976-08-01
SE388420B (sv) 1976-10-04
HU169273B (de) 1976-10-28
DD110869A5 (de) 1975-01-12
SU505348A3 (ru) 1976-02-28
BE809179A (fr) 1974-06-27
IL43749A (en) 1977-06-30
NL169472B (nl) 1982-02-16
ATA1089973A (de) 1976-03-15
CH592641A5 (de) 1977-10-31
GB1453703A (en) 1976-10-27
DK145574B (da) 1982-12-13
NL7317536A (de) 1974-07-02
IL43749A0 (en) 1974-03-14
CH590253A5 (de) 1977-07-29
JPS5422978B2 (de) 1979-08-10
CS186258B2 (en) 1978-11-30
AR207336A1 (es) 1976-09-30
JPS5356664A (en) 1978-05-23
DE2362754A1 (de) 1974-07-11
AT333272B (de) 1976-11-10
ZA739694B (en) 1975-02-26
IL49288A (en) 1977-06-30
US3988464A (en) 1976-10-26
SU591136A3 (ru) 1978-01-30
JPS5359665A (en) 1978-05-29
JPS5335949B2 (de) 1978-09-29
JPS544955B2 (de) 1979-03-12
JPS504084A (de) 1975-01-16

Similar Documents

Publication Publication Date Title
KR0179661B1 (ko) N-페닐알킬 치환된 알파-아미노 카복스아미드 유도체 및 이를 포함하는 약제학적 조성물 및 이의 제조방법
FR2500450A1 (fr) Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
FI59999C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla cyklopropylmetylamino- 2-oxazoliner
EP0773937A1 (de) Von arylpiperazinen abgeleitete piperzide und ihre verwendung als medikament
FR2504920A1 (fr) Derives phenylcyclobutyliques, leur procede de preparation et leur application therapeutique
CA1116611A (en) Imidazole derivatives exhibiting anticonvulsant activity
FR2673182A1 (fr) Piperazines n,n'-disubstituees, leur procede de preparation et leur application en therapeutique.
US4077999A (en) Novel oxime ethers
EP0174242B1 (de) 1-(Aminophenyl)-2-amino-propanon-Derivate, deren Verwendung in Therapie und Verfahren zu deren Herstellung
US2774770A (en) Sulfur-containing amines
KR0178366B1 (ko) 벤젠 유도체, 그 제조방법 및 그를 함유하는 약학 조성물
EP0077427B1 (de) Piperidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0002978B1 (de) Thiazolidindion-2,4 Derivate, deren Herstellung und Verwendung als Arzneimittel
DK149043B (da) Analogifremgangsmaade til fremstilling af 2-benzal- eller 2-benzyl-1-(aminoalkoxyimino)-cykloalkaner eller salte eller kvaternaere ammoniumderivater deraf
FR2460294A1 (fr) Nouveaux oxime-ethers, leur procede de preparation et compositions pharmaceutiques les contenant
EP0037344B1 (de) Amino-alkoxy-pyrazole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
FI67216B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,-ditiolanyl(2)- och 1,3-ditianyl(2)-foereningar
EP0338937B1 (de) 1-[3-(4-Hydroxy-phenyl)-1-hydroxy-1-propyl]-2-amino-alkylenoxy-benzen-Derivate und deren therapeutische Verwendung
FR2470770A1 (fr) Nouveaux ethers de b-imidazolylethyle de quinoleine-2 ou 4-methanols, utiles notamment comme antimicrobiens, et leur procede de preparation
US3720714A (en) 2-alkoxy-2(naphthyl)-alkanamidoximes
FR2585702A1 (fr) Derives de phenyl-piperazine, procede de preparation et utilisation en therapeutique
US4727180A (en) Antihypertensive polyhalohydroxylisopropyl phenylalkanoic and phenylalkenoic acids, amides and esters and intermediates thereto
US3639478A (en) N n-alkylenebis(2-lower alkoxy) - 2-sub-stituted-alkanamidines) and their preparation
FI59095C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefullt 2-(dicyklopropylmetylamino)-tiazolin och salter haerav
EP0210885B1 (de) Derivate von primären Halobiphenylalkoholen, die bei Therapeutik verwendbar sind zur Behandlung von Arterienverkalkung